You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

Article metrics

Article menu

Download PDFPDF

Short Report
Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019110
Jan 202014140
Feb 2020545418
Mar 2020737327
Apr 202076768
May 202077773
Jun 2020515110
Jul 2020464619
Aug 2020343428
Sep 2020777721
Oct 2020828226
Nov 2020686830
Dec 2020565512
Jan 2021606013
Feb 2021666621
Mar 2021545418
Apr 2021808033
May 2021717125
Jun 2021868618
Jul 2021535314
Aug 2021545419
Sep 2021727219
Oct 2021757523
Nov 2021575818
Dec 2021737413
Jan 2022798522
Feb 2022638027
Mar 202259619
Apr 202210210313
May 20222502528
Jun 2022979811
Jul 2022606111
Aug 202211711913
Sep 202210010017
Oct 2022868918
Nov 202211912028
Dec 2022838410
Jan 2023808012
Feb 202311611614
Mar 202316016016
Apr 202313013124
May 20239610021
Jun 202311611619
Jul 202311411521
Aug 2023959625
Sep 202311711823
Oct 202312912920
Nov 202319519630
Dec 202321821821
Jan 202411111213
Feb 202416716719
Mar 202416716733
Total47364784934